Hippocratic AI valued at 3.5 billion after 126 million funding round

Hippocratic AI, a healthcare-focused artificial-intelligence startup, has secured $126 million in its latest funding round led by Avenir Growth, raising its valuation to about $3.5 billion. The company uses generative-AI models to support clinical decision-making and drug-development insights. Investors maintain strong appetite for AI companies with healthcare applications, even as valuations remain elevated. Analysts caution that commercial execution and regulatory compliance will be key next-step challenges for Hippocratic AI’s ambitious growth trajectory.